Please login to the form below

Not currently logged in
Email:
Password:

Mannatech creates global scientific advisory board

Appoints Dr Steve Nugent as chairman of the board

Texas-based Mannatech, a global health and wellness company, has assembled a global scientific advisory board to provide support for the development and review of its products.

The firm has appointed nine third-party scientists to the advisory board who will be tasked with driving innovation in new product development and ensuring that all products meet the highest standards.

Alfredo Bala, Manatech's chief executive officer and president, said: “The members of Mannatech's global scientific advisory board are committed to science and the truth that their research and findings bring.

“Mannatech has built its worldwide business on science-backed product technology and this group will help us continue that tradition and take us into new, transformational areas of health and wellness, while ensuring we stay on the path of scientific proof and validation.”

Mannatech's senior global wellness director Dr Steve Nugent has been appointed as chairman of the board, while the company's director of clinical research and scientific affairs Dr Rolando Maddela will serve as the board's executive secretary.

Dr Nugent brings over 38 years of experience in the health and wellness industry to the board, having joined Mannatech in 1995.

He said: “It is a great honour for me to be asked to lead an independent board of experts to help continue Mannatech's tradition of producing products validated by science.”

Dr Nugent and Dr Maddela will be supported in their roles by Tait Switzer, vice president of research and development at Mannatech.

28th April 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics